Breckenridge Pharmaceutical, Inc. is recalling 3,146 bottles of Omeprazole Delayed-Release Capsules (20 mg, 1000 count bottles) because stability testing discovered unknown impurities that exceeded safety specifications. These prescription capsules are used to treat certain stomach and esophagus problems, such as acid reflux and ulcers. Consumers who have the affected medication should contact their doctor or pharmacist immediately as these impurities represent a failure to meet the drug's quality and degradation standards.
Testing revealed the presence of unknown chemical impurities or degradation products that exceeded approved safety limits. While the specific health impact of these impurities is unknown, taking medication that does not meet chemical specifications can result in reduced effectiveness or exposure to unintended substances.
Healthcare consultation and refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.